Related Experiment Videos
Changing management of pyogenic liver abscess
R Rintoul1, M G O'Riordain, I F Laurenson
1University Department of Surgery, Royal Infirmary, Edinburgh, UK.
The British Journal of Surgery
|September 1, 1996
Summary
Pyogenic liver abscess (PLA) management primarily involves percutaneous drainage and antibiotics. However, malignancy-associated PLA significantly increases mortality, highlighting a critical challenge in treating this condition.
Area of Science:
- Hepatology
- Infectious Diseases
- Interventional Radiology
Background:
- Pyogenic liver abscess (PLA) is a serious condition requiring prompt diagnosis and treatment.
- Ascending cholangitis and hematogenous spread are common etiologies.
- Underlying malignancy, particularly biliary obstruction, is an increasingly recognized risk factor.
Purpose of the Study:
- To review the management and outcomes of patients with pyogenic liver abscess.
- To identify factors influencing treatment success and mortality.
- To assess the role of percutaneous drainage in PLA management.
Main Methods:
- Retrospective review of 23 patient case records over a 5-year period.
- Analysis of presenting diagnoses, implicated causes, and treatment modalities.
- Evaluation of treatment outcomes based on underlying pathology (benign vs. malignant).
Main Results:
- Percutaneous abscess drainage was the primary treatment in 15 patients.
- Successful management was observed in 9 of 11 patients with benign conditions.
- All four patients with malignant biliary obstruction did not survive; only one patient required surgery.
Conclusions:
- Percutaneous drainage with antibiotics is effective for PLA, but outcomes depend heavily on the underlying cause.
- Malignant biliary obstruction presents a substantial challenge, leading to high mortality rates.
- Increasing incidence of malignancy-associated PLA necessitates improved diagnostic and therapeutic strategies.